CardioVascular BioTherapeutics (CVBT.OB) - FDA- approved interventional cardiac Phase II clinical trial
Cardio has announced an FDA- approved interventional cardiac Phase II clinical trial in a support partnership with Cordis (JnJ). With a true placebo-controlled protocol now possible, the direct heart injection …
From Research Connect – Latest Financial Reports
